Delivery Order SPE2DB22D9239-SPE2DB23FDL46
Award Date 8/2/23
Potential Completion Date 8/23/23
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the pharmaceutical product "LETAIRIS 5 MG TABLET UU 10S" with a ceiling value of $2,004.28. The order is issued under an existing Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows DLA to place firm fixed-price delivery orders for a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,006.42 firm fixed-price contract is for the delivery of Letairis 5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the Medical Supply Chain...
- The Defense Logistics Agency Troop Support Medical awarded a $86,680 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4561623282 units of 45mcg levalbuterol tartrate inhalation to be delivered by July 27, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment for troops and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,019.26 by the Defense Logistics Agency Troop Support Medical. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under this order, DMS Pharmaceutical Group will provide 30 tablets of Letairis 10 mg to the Park Ridge, Illinois location of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at forty-five thousand nine hundred twenty dollars to DMS Pharmaceutical Group Incorporated, located in Park Ridge, Illinois. The order is for thirty tablets of Leflunomide, a disease-modifying antirheumatic drug, to be delivered between June 23 and June 26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics supply chain and distribution network as part of...
- The Defense Logistics Agency awarded a $36,297.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,600 MCG tablets of UPTRAVI (a pulmonary hypertension treatment) in a 60-count package. The delivery order, which carries no set-aside designation, was awarded on November 5, 2025, with an ultimate completion date of November 28, 2025. DMS Pharmaceutical Group is the sole contractor on this...
- The Defense Logistics Agency Troop Support Medical awarded a $103,320 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 30 packages containing 20 mg tablets of Leflunomide. The place of performance is Park Ridge, Illinois and the period of performance is one day from June 22, 2023 to June 23, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring and distributing medical supplies to support military...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $520 firm fixed price delivery order for Tadalafil 5 mg tablets. The order is for 30 tablets and has a completion date of September 25, 2023. The place of performance is Park Ridge, Illinois. No set-aside designation was used for this award placed under an unidentified contracting vehicle. The Defense Logistics Agency supports America's armed forces by providing supplies in the areas of food, clothing, medicines, fuel and...
- The Defense Logistics Agency Troop Support Medical awarded a $16,600 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 30 boxes of 10mg Leflunomide tablets. The place of performance is DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is one day, from June 22, 2023 to June 23, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.30 to DMS Pharmaceutical Group Inc. for 90 tablets of Letrozole 2.5 mg on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order represents a routine pharmaceutical supply transaction issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating it was competed on an...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDL46Delivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,004.28 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561704288 LETAIRIS 5 MG TABLET UU 10S. The place of performance will be Park Ridge, Illinois. The period of performance is from August 2, 2023 through August 23, 2023. No set aside designation or subcontractors were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply the branded pulmonary arterial hypertension drug Letairis to support the Agency's medical materiel programs.
Generated 12/17/23, 4:30 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/2/23 |